| answer text |
<p>The Cortisone Programme is scheduled to achieve Initial Operating Capability (IOC)
in July 2022 with the roll-out of new Primary Medical Care IT services to fixed medical
treatment facilities, in the UK and overseas. IOC will be deemed achieved when 80%
of the MTFs are successfully operating the new services. Some user benefits from the
Programme are expected earlier, from January 2021, when the medical information services
interface between the Ministry of Defence and the National Health Service is improved.</p><p>Cortisone
capability will be brought into service through Agile delivery methodologies. The
Cortisone business case, approved in 2018, contained a model of the anticipated cost
of delivery, rather than a firm cost provided by a preferred bidder. The model has
been demonstrated to be robust, and we are confident that the capability expressed
in the business case can be delivered with the funds approved.</p>
|
 |
